PL356482A1 - Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii - Google Patents

Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii

Info

Publication number
PL356482A1
PL356482A1 PL00356482A PL35648200A PL356482A1 PL 356482 A1 PL356482 A1 PL 356482A1 PL 00356482 A PL00356482 A PL 00356482A PL 35648200 A PL35648200 A PL 35648200A PL 356482 A1 PL356482 A1 PL 356482A1
Authority
PL
Poland
Prior art keywords
topomerase
phenazin
benzo
carboxamide derivatives
inhibitors
Prior art date
Application number
PL00356482A
Other languages
English (en)
Polish (pl)
Inventor
John Milton
Nigel Vicker
Adrian FOLKES
Shouming Wang
William Alexander Denny
Original Assignee
Xenova Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Limited filed Critical Xenova Limited
Publication of PL356482A1 publication Critical patent/PL356482A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/46Phenazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL00356482A 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii PL356482A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928542.1A GB9928542D0 (en) 1999-12-02 1999-12-02 Pharmaceutical compounds
PCT/GB2000/004609 WO2001046157A1 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii

Publications (1)

Publication Number Publication Date
PL356482A1 true PL356482A1 (en) 2004-06-28

Family

ID=10865607

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356482A PL356482A1 (en) 1999-12-02 2000-12-01 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii

Country Status (16)

Country Link
EP (1) EP1240148A1 (xx)
JP (1) JP2003518103A (xx)
KR (1) KR100767613B1 (xx)
CN (1) CN1304380C (xx)
AU (1) AU784397B2 (xx)
BR (1) BR0016093A (xx)
CA (1) CA2392873A1 (xx)
GB (2) GB9928542D0 (xx)
HK (1) HK1046133B (xx)
HU (1) HUP0300392A3 (xx)
MX (1) MXPA02005476A (xx)
MY (1) MY136029A (xx)
PL (1) PL356482A1 (xx)
TW (1) TWI280242B (xx)
WO (1) WO2001046157A1 (xx)
ZA (1) ZA200204296B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2433071A (en) * 2005-12-05 2007-06-13 Kontrakt Technology Ltd Organic acids comprising planar conjugated heterocyclic molecular system, & photoelectric layer thereof with rodlike supramolecules for use in solar cell
CN102898388B (zh) * 2012-09-26 2014-12-03 浙江工业大学 一种合成取代苯并[α]吩嗪类化合物的方法
CN103360329B (zh) * 2013-07-18 2015-11-18 中国科学院南海海洋研究所 一类吩嗪化合物及其在制备抗肿瘤药物中的应用
CN106554321B (zh) * 2015-09-25 2019-05-28 陆源 一种吩嗪类物质、其制备方法及其应用
CN113461623A (zh) * 2021-07-14 2021-10-01 长江大学 一种抗病毒化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE195869T1 (de) * 1992-05-28 2000-09-15 Xenova Ltd Acridin carboxamide zur behandlung von krebs
US5696131A (en) * 1993-01-22 1997-12-09 Xenova Limited Treatment of cancers
TR199900636T2 (xx) * 1996-09-23 1999-10-21 Rutgers, The State University Of New Jersey Anti-t�m�r ajanlar� olarak ikameli/katk�l� heterosayk�llar.
WO1998045272A1 (en) * 1997-04-07 1998-10-15 Latrobe University Topoisomerase inhibitors

Also Published As

Publication number Publication date
GB2373499A (en) 2002-09-25
GB2373499B (en) 2004-11-17
KR20020070305A (ko) 2002-09-05
HUP0300392A2 (hu) 2003-07-28
BR0016093A (pt) 2002-08-20
CA2392873A1 (en) 2001-06-28
TWI280242B (en) 2007-05-01
HK1046133B (zh) 2005-04-15
CN1433406A (zh) 2003-07-30
CN1304380C (zh) 2007-03-14
KR100767613B1 (ko) 2007-10-19
JP2003518103A (ja) 2003-06-03
MY136029A (en) 2008-07-31
AU1718401A (en) 2001-07-03
GB9928542D0 (en) 2000-02-02
HK1046133A1 (en) 2002-12-27
GB0215275D0 (en) 2002-08-14
EP1240148A1 (en) 2002-09-18
ZA200204296B (en) 2003-05-29
MXPA02005476A (es) 2003-09-22
WO2001046157A1 (en) 2001-06-28
HUP0300392A3 (en) 2003-09-29
AU784397B2 (en) 2006-03-23

Similar Documents

Publication Publication Date Title
SI1475377T1 (sl) Indolni derivati in njihova uporaba kot inhibitorji fosfodiesteraze 4
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
GB2374100B (en) Underreamer and method of use
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
PL337773A1 (en) Derivatives of benzimidazoles
PL351261A1 (en) Derivatives of indigoid bisindoles
AU7648698A (en) Heterocyclic derivatives and their use as antithrombotic agents
HUP0004512A3 (en) 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
PL331047A1 (en) Novel amidinic derivatives and their application as inhibitors of thrombosin
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
IL146000A0 (en) Ace-2 inhibiting compounds and methods of use thereof
PL352296A1 (en) Crystalline derivatives of 1-methylocarbapeneme
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
IL143987A0 (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors
HUP0201925A3 (en) Cyclic peptide derivatives as inhibitors of integrin alphavbeta6 and their use
PL352401A1 (en) Method of making nitroguanidine and nitroenamine derivatives
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
PL356482A1 (en) Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii
HK1066804A1 (en) Derivatives of indole and their use as phosphodiesterase 4 inhibitors
IL149534A0 (en) Preparation of 3-substituted-4-arylquinolin-2-one derivatives
IL145600A0 (en) Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
HK1033128A1 (en) Benzo[c]quinolzine derivatives and their use as 5 alpha-reductases inhibitors
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
PL355845A1 (en) Substituted isoquinoline derivatives and their use as inticonvulsants

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)